Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theresa N Ramos

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Trends in Parasitology|April 5, 2014
Experimental cerebral malaria: the murine model provides crucial insight into the role of complementTheresa N Ramos-Summerford, Scott R Barnum
Neuroscience Letters|October 24, 2009
Deletion of both the C3a and C5a receptors fails to protect against experimental autoimmune encephalomyelitisTheresa N Ramos, Jillian E Wohler, Scott R Barnum
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 9, 2014
Deletion of C-reactive protein ameliorates experimental cerebral malaria?Alexander J Szalai, Scott R Barnum, Theresa N Ramos
Epilepsia|November 12, 2014
Complement C5-deficient mice are protected from seizures in experimental cerebral malariaSusan C Buckingham, Theresa N Ramos, Scott R Barnum
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2014
ICAM-1: isoforms and phenotypesTheresa N Ramos, Daniel C Bullard, Scott R Barnum
European Journal of Immunology|January 18, 2014
Expression of a single ICAM-1 isoform on T cells is sufficient for development of experimental autoimmune encephalomyelitisDaniel C Bullard, Xianzhen Hu, David Crawford, et al.
JCI Insight|October 5, 2016
Soluble membrane attack complex is diagnostic for intraventricular shunt infection in childrenTheresa N Ramos, Anastasia A Arynchyna, Tessa E Blackburn, et al.
The Journal of Biological Chemistry|June 13, 2012
The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malariaTheresa N Ramos, Meghan M Darley, Sebastian Weckbach, et al.
Molecular Immunology|January 23, 2013
Therapeutic inhibition of the alternative complement pathway attenuates chronic EAEXianzhen Hu, V Michael Holers, Joshua M Thurman, et al.
The Journal of Biological Chemistry|March 16, 2013
Experimental cerebral malaria develops independently of endothelial expression of intercellular adhesion molecule-1 (icam-1)Theresa N Ramos, Daniel C Bullard, Meghan M Darley, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Trends in Parasitology|April 5, 2014
Experimental cerebral malaria: the murine model provides crucial insight into the role of complementTheresa N Ramos-Summerford, Scott R Barnum
Neuroscience Letters|October 24, 2009
Deletion of both the C3a and C5a receptors fails to protect against experimental autoimmune encephalomyelitisTheresa N Ramos, Jillian E Wohler, Scott R Barnum
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 9, 2014
Deletion of C-reactive protein ameliorates experimental cerebral malaria?Alexander J Szalai, Scott R Barnum, Theresa N Ramos
Epilepsia|November 12, 2014
Complement C5-deficient mice are protected from seizures in experimental cerebral malariaSusan C Buckingham, Theresa N Ramos, Scott R Barnum
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2014
ICAM-1: isoforms and phenotypesTheresa N Ramos, Daniel C Bullard, Scott R Barnum
European Journal of Immunology|January 18, 2014
Expression of a single ICAM-1 isoform on T cells is sufficient for development of experimental autoimmune encephalomyelitisDaniel C Bullard, Xianzhen Hu, David Crawford, et al.
JCI Insight|October 5, 2016
Soluble membrane attack complex is diagnostic for intraventricular shunt infection in childrenTheresa N Ramos, Anastasia A Arynchyna, Tessa E Blackburn, et al.
The Journal of Biological Chemistry|June 13, 2012
The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malariaTheresa N Ramos, Meghan M Darley, Sebastian Weckbach, et al.
Molecular Immunology|January 23, 2013
Therapeutic inhibition of the alternative complement pathway attenuates chronic EAEXianzhen Hu, V Michael Holers, Joshua M Thurman, et al.
The Journal of Biological Chemistry|March 16, 2013
Experimental cerebral malaria develops independently of endothelial expression of intercellular adhesion molecule-1 (icam-1)Theresa N Ramos, Daniel C Bullard, Meghan M Darley, et al.
Pageof 2